Short answer
Boston Scientific (BSX) filed an 8-K current report with the SEC on July 27, 2026 reporting Item 2.05 (Costs Associated with Exit or Disposal Activities). New global restructuring program runs through 2029, targeting supply-chain optimization and organizational efficiencies.
Boston Scientific 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.05 · Costs Associated with Exit or Disposal Activities
- New global restructuring program runs through 2029, targeting supply-chain optimization and organizational efficiencies
- Estimated pre-tax charges of $700–$800 million, including $600–$700 million in future cash outlays
- Annual gross pre-tax expense reduction of approximately $500 million, with substantial savings reinvested in growth initiatives
- Cost mix includes $300–$350 million transfers, $275–$300 million termination benefits, and $125–$150 million other costs
- Some headcount reductions expected despite new hiring in growth areas, creating execution and workforce-transition risks
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Boston Scientific 8-K filings
Get the next BSX 8-K as it lands
Follow BSX for push alerts, or ask the research agent what this filing means.